Picture of Cryosite logo

CTE Cryosite Income Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapFalling Star

Annual income statement for Cryosite, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
C2021
June 30th
R2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue7.979.011011.811.9
Cost of Revenue
Gross Profit3.374.045.896.847.17
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses8.267.258.819.8810.4
Operating Profit-0.2881.771.211.881.52
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.2881.771.121.811.57
Provision for Income Taxes
Net Income After Taxes-0.5651.480.6531.361.41
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-1.721.480.6531.361.41
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1.721.480.6531.361.41
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.0070.0140.0140.0280.029
Dividends per Share